AU5827000A - Viral il-10 uses - Google Patents

Viral il-10 uses

Info

Publication number
AU5827000A
AU5827000A AU58270/00A AU5827000A AU5827000A AU 5827000 A AU5827000 A AU 5827000A AU 58270/00 A AU58270/00 A AU 58270/00A AU 5827000 A AU5827000 A AU 5827000A AU 5827000 A AU5827000 A AU 5827000A
Authority
AU
Australia
Prior art keywords
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58270/00A
Inventor
Maria Teresa Bejarano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5827000A publication Critical patent/AU5827000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU58270/00A 1999-07-16 2000-07-11 Viral il-10 uses Abandoned AU5827000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35483399A 1999-07-16 1999-07-16
US09354833 1999-07-16
US16362799P 1999-11-04 1999-11-04
US60163627 1999-11-04
PCT/EP2000/006558 WO2001005821A2 (en) 1999-07-16 2000-07-11 Viral il-10 for the inhibition of angiogenesis, tumorigenesis and metastasis

Publications (1)

Publication Number Publication Date
AU5827000A true AU5827000A (en) 2001-02-05

Family

ID=26859813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58270/00A Abandoned AU5827000A (en) 1999-07-16 2000-07-11 Viral il-10 uses

Country Status (2)

Country Link
AU (1) AU5827000A (en)
WO (1) WO2001005821A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367891T3 (en) 2000-09-29 2011-11-10 Schering Corporation INTERLEUCINA-10 PEGILADA.
JPWO2002066069A1 (en) * 2001-02-20 2004-09-24 関西ティー・エル・オー株式会社 Inflammatory / neoplastic disease treatment
JP5105554B2 (en) * 2006-09-28 2012-12-26 メルク・シャープ・アンド・ドーム・コーポレーション Use of pegylated IL-10 to treat cancer
EP2379115B1 (en) 2008-12-17 2017-10-25 Merck Sharp & Dohme Corp. Mono- and di-peg il-10 production; and uses
BR112015026122A8 (en) 2013-04-18 2020-01-21 Armo Biosciences Inc polyethylene glycol-yl-10 agent (peg-il-10), its use, pharmaceutical composition, sterile container and kit
US9823255B2 (en) 2013-06-17 2017-11-21 Armo Biosciences, Inc. Method for assessing protein identity and stability
AU2014311432A1 (en) 2013-08-30 2016-03-03 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
BR112016010166A2 (en) 2013-11-11 2017-12-05 Armo Biosciences Inc Methods for Using Interleukin-10 to Treat Diseases and Disorders
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
CN107106655A (en) 2014-10-22 2017-08-29 阿尔莫生物科技股份有限公司 The method that disease and illness are treated using interleukin 10
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
KR20180020141A (en) 2015-05-28 2018-02-27 아르모 바이오사이언시스 인코포레이티드 PEGylated interleukin-10 for cancer treatment
WO2017035232A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE116550T1 (en) * 1991-01-16 1995-01-15 Schering Corp TREATMENT OF NEOPLASTIC DISEASES WITH INTERLEUKIN-10.
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10

Also Published As

Publication number Publication date
WO2001005821A2 (en) 2001-01-25
WO2001005821A3 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU4127699A (en) Z-stud structural member
AU2678800A (en) Modified calycins
AU1285300A (en) Hiv vaccine
AU5827000A (en) Viral il-10 uses
AUPP967999A0 (en) Viral variants
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU7514700A (en) Cyanopiperidines
AU2023701A (en) Sketcher
AU6440900A (en) Homogentisate-dioxygenase
AU2804600A (en) Arylaminoalkylamides
AU7346100A (en) Cytomegalovirus-encoded il-10 homolog
AU2699800A (en) Organoceramics
AU4916900A (en) Benzofuranylsulfonates
AU6098300A (en) Follistatin-3
AU2359301A (en) Novel ss-defensins
AU2579700A (en) Frame member
AU4561600A (en) Benzofuranylaminoalcohols
AU1042701A (en) Antiviral combinations
AU3086800A (en) Injection-administered antiviral preparation
AU1901801A (en) Glucofuranoses
AU4435300A (en) Hula-hoop

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase